RE:NEVER SEEN BEFOREIt doesn't really matter what the facts are on other companies. The media is now mentioning Concordia alongside Valeant and Turing. Granted they are saying Concordia is not as extreme. If you were a new investor would you be rushing to put fresh money into a company mentioned in the same breath as these other clowns? The chart is telling me otherwise. The short side has successfully put Concordia in the medias crosshairs and have positioned themselves to make a killing if the the "leaked" buyout rumors don't come true fast.
fdfd12 wrote:
This type of analysis for a company.
How much did they raise prices? For which drugs they raised?
Is there a decline in volumes?
How amy % declines in volumes compared to price increases?
DOES ANYONE GO AND DO THIS TO MERCK PFEIZER OR JNJ?